Funding for this research was provided by:
Canadian Institutes of Health Research (FDN-143330)
Fondazione Telethon (TCR13001)
FSHD Global Research Foundation
ERA-Net for Research on Rare Diseases
Received: 23 October 2017
Accepted: 15 February 2018
First Online: 6 March 2018
Ethics approval and consent to participate
: Not applicable
: KN, DG, and FJD declare no competing interests. CG is a consultant for Gene Tools. Funding bodies had no role in writing this review.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.